Document is current
Any future updates will be listed below
-
Authors
Buhl, Rebecca
Yildirim, Timur Mert
Schickhardt, Sonja Katrin
Britz, Leoni
Lieberwirth, Ingo
Auffarth, Gerd Uwe
Khoramnia, Ramin
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 30 April 2024
Accepted: 1 July 2024
First Online: 23 August 2024
Declarations
:
: Not applicable.
: Not applicable.
: R. Buhl, S. Schickhardt, L. Britz, and I. Lieberwirth declare that they have no competing interests. T. Yildirim reports personal fees from Alcon. R. Khoramnia reports grants, personal fees and non-financial support from Alimera, Alcon, Bayer, Johnson & Johnson, Hoya, Novartis, Physiol, Rayner and Roche, grants from Chengdu Kanghong, personal fees and non-financial support from Allergan, Kowa, Oculentis/Teleon, Oculus, Santen, and Acufocus. G. Auffarth reports grants, personal fees, non-financial support and consulting fees from Johnson & Johnson and Alcon, grants, personal fees and non-financial support from Carl Zeiss Meditec, Hoya, Kowa, Oculentis/Teleon, Rayner, Santen, Sifi, and Ursapharm, grants and personal fees from Biotech, Oculus, and EyeYon, grants from Acufocus, Anew, Contamac, Glaukos, Physiol, and Rheacell.
